diphenhydramine has been researched along with orabase in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erofeeva, L; Lazarev, A; Piskunov, G; Piskunov, S; Razinkov, S | 1 |
Simon, HB | 1 |
Hayashi, T; Kanbe, H; Onuki, Y; Sonobe, T | 1 |
Brown, GC; Dreyer, LN | 1 |
4 other study(ies) available for diphenhydramine and orabase
Article | Year |
---|---|
The prolongation of drug action in the treatment of diseases of the nose and paranasal sinuses.
Topics: Animals; Biological Availability; Carboxymethylcellulose Sodium; Diphenhydramine; Dosage Forms; Instillation, Drug; Liver; Male; Methylcellulose; Nose Diseases; Paranasal Sinus Diseases; Rabbits; Ranidae; Rats; Solutions; Time Factors | 1993 |
On call: I am a 71-year-old man with diabetes and high blood pressure. Ever since I can remember, I've been bothered by painful canker sores two or three times a year. My doctor says they aren't caused by my medication and I think he's right, since the ca
Topics: Aged; Anesthetics, Local; Carboxymethylcellulose Sodium; Diphenhydramine; Drug Combinations; Humans; Lidocaine; Magnesium Oxide; Male; Stomatitis, Aphthous | 2004 |
Manufacture of fine spherical granules by an extrusion/spheronization method.
Topics: Carboxymethylcellulose Sodium; Cellulose; Diphenhydramine; Drug Compounding; Excipients; Feasibility Studies; Particle Size; Powders; Pressure; Surface Properties; Technology, Pharmaceutical; Water | 2007 |
Oral manifestations of psoriasis. Clinical presentation and management.
Topics: Alefacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carboxymethylcellulose Sodium; Diphenhydramine; Etanercept; Glossitis, Benign Migratory; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Lip Diseases; Methotrexate; Mouth Diseases; Mouth Mucosa; Palliative Care; Psoriasis; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins | 2012 |